Giving children the best possible start in life
InfanDx's mission is to improve clinical decision making in prenatal and neonatal care through non-invasive, early, and accurate prenatal genetic screening

About Us

InfanDx AG is a privately held company focusing on the development and commercialization of novel diagnostic solutions for child health. Lead by a team of seasoned industry experts, InfanDx initially focused on the development of a test for the early detection of hypoxic-ischemic encephalopathy.

The Company shifted focus in 2023 to non-invasive prenatal screening. Based on a proprietary in-licensed technology InfanDx aims to take non-invasive prenatal testing beyond the current scope of chromosome copy number variations (aneupolodies) and large structural variations of DNA to testing of microdeletions and point mutations causative to a large number of genetic diseases. The initial focus of InfanDx's product pipeline lies on taking functional newborn screening for common monogenetic conditions, the current standard-of-care, to an early prenatal stage by non-invasive prenatal genetic screening.

The Company is headquartered in Cologne, Germany, with a branch office in Berlin, Germany, and a wholly owned subsidiary in Boston, MA, USA.

For more information see here:
Corporate Presentation (pdf)
Leadership Management
InfanDx Team combines seasoned diagnostics industry leaders with high-potentials that are talented experts in their respective disciplines.

Dr. Achim Plum

Chief Executive Officer | Managing Director
read more

Dr. Gunter Weiss

Chief Operating Officer
read more

Jordan deVos

Vice President, US Operations
read more

PD Dr. Aisha Munk, MD

Head of Medical Science
read more

Thomas König

Senior Biostatistician
read more

Nathaly Schäfer

Corporate Affairs Manager
read more

Noodle vom Dachsfelsen

Corporate Security Officer
read more

Supervisory Board

InfanDx Supervisory Board combines life science industry experts with serial entrepreneurs and investment professionals.

Wolfgang Kintzel

Chairman of the Supervisory Board, CEO Cellbox Solutions
read more

Paul Owsianowski

Active Ownership Capital S.à r.l.
read more

Dr. Jörg Fregien

Managing Director, Life Science Inkubator GmbH
read more

Dr. Wolfgang Schwandner

Owner, Arnika Beteiligungen GmbH
read more

Gerhard Albert

Owner CVG Capital GmbH
read more

Klaus Albrecht

Head of Family Office, Alluti GmbH
read more

Scientific Advisory Board

Our distinguished Scientific Advisory Board provides us with access to unparalleled scientific and clinical expertise in neonatal diagnostics, metabolomics, and biostatistics - on a daily basis.
No items found.

Scientific Advisory

No items found.